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Primordial follicles or non-growing follicles (NGFs) are the functional unit of reproduction,
each comprising a single germ cell surrounded by supporting somatic cells. NGFs
constitute the ovarian reserve (OR), prerequisite for germ cell ovulation and the
continuation of the species. The dynamics of the reserve is determined by the number
of NGFs formed and their complex subsequent fates. During the reproductive lifespan,
the OR progressively diminishes due to follicle atresia as well as recruitment, maturation,
and ovulation. The depletion of the OR is the major determining driver of menopause,
which ensues when the number of primordial follicles falls below a threshold of 1,000.
Therefore, genes and processes involved in follicle dynamics are particularly important to
understand the process of menopause, both in the typical reproductive lifespan and in
conditions like primary ovarian insufficiency, defined as menopause before age 40. Genes
and their variants that affect the timing of menopause thereby provide candidates for
diagnosis of and intervention in problems of reproductive lifespan. We review the current
knowledge of processes and genes involved in the development of the OR and in the
dynamics of ovarian follicles.
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INTRODUCTION
The growing trend in all contemporary societies for childbearing later in women’s lives, accompanied
by the increasing use of assisted reproduction technology, make the term ovarian reserve (OR)
increasingly prominent in medical and scientific literature. Coined more than 25 years ago by
Navot et al. (1987), it occurs in at least 1,500 papers currently in PubMed, with an exponentially
increasing prevalence. However, the concept of OR is rarely defined, and varies in its usage in
different contexts. In current clinical literature OR unambiguously signifies the number and quality
of the follicles remaining in an ovary at any given time (Broekmans et al., 2006) or a woman’s
reproductive potential as a function of the number and quality of her remaining oocytes (American
College of Obstetricians and Gynecologists (ACOG), 2015). By contrast, the research literature
considers that themammalian ovary contains two functional pools: a pool of resting or non-growing
follicles (NGFs) and another of growing follicles. A resting follicle is “primordial,” comprised of
an oocyte surrounded by a single layer of flattened somatic pre-granulosa cells and arrested in the
diplotene/dictyate stage of meiotic prophase I. Such a follicle continues to be quiescent throughout
life unless it is lost by atresia or recruited for maturation. By contrast, the growing follicles have been
activated to various stages of maturation in the process now generally called folliculogenesis. The
“activated” pool includes primary, secondary, preantral, antral, and preovulatory or Graafian follicles
(Gougeon, 1986). Several other terms have been proposed, including “ovulatory potential” (Findlay
et al., 2015) or “dynamic reserve” (Monniaux et al., 2014), for the growing follicle pool that supports
normal folliculogenesis and can potentially be ovulated or induced to maturity (e.g., in assisted
conception).
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In this discussion, adopting the preponderant view in the field,
OR is considered as the size of the NGF pool in a woman’s two
ovaries at any given age. This is the most valid measure of female
reproductive lifespan.
However, the assessment of human OR remains technically
problematic. Especially because follicles are unevenly distributed
in the ovarian cortex (van Wagenen and Simpson, 1965; Sforza
et al., 2003), invasive and partially destructive methods, such as
ovarian biopsy, do not yield a reliable estimate of theOR (Lambalk
et al., 2004; Lass, 2004), and direct in vivo counting is currently not
possible.
A number of non-invasive procedures, including
determination of ovarian volume, antral follicle count (AFC),
and certain serum markers, have been proposed singly and in
combination to assess the OR for individual women (American
College of Obstetricians and Gynecologists (ACOG), 2015), but
none of these procedures has been shown to be directly related to
the size of the OR (Findlay et al., 2015). It has been observed that
these procedures are a measure of “ovarian response” rather than
a measure of OR (Nelson, 2014).
The most reliable route to assess the OR is to remove ovaries
and carry out histomorphometry-based follicle counts in serial
tissue sections of the entire ovaries (Tilly, 2003). To date, using this
method on tissues retrieved post-mortem or post-oophorectomy,
there have been six studies that estimated the OR in females at
various chronological ages. Two of these studies have evaluated
the OR in the phase of its formation (Block, 1953; Forabosco and
Sforza, 2007), and four have focused on OR dynamics from birth
to menopause (Block, 1952; Richardson et al., 1987; Gougeon
et al., 1994; Hansen et al., 2008). These studies have shown that
the OR increases dramatically from 15 weeks of post-conception
(wpc) until the 34th wpc, and thereafter remains constant, with
an average of about 680,000 NGFs, until at least 2 years after birth
(Block, 1953; Forabosco and Sforza, 2007; Hansen et al., 2008).
As for the OR in postnatal life, before puberty quantitative data
are scanty. There are no data between 2 and 7 years, and from
7 to 12 years the measures show considerable variability (Block,
1952; Hansen et al., 2008). The available data indicate a limited
decrement from early postnatal numbers. An average of460,000
of follicles remains around puberty (age 12–14; Block, 1952;
Hansen et al., 2008). Thereafter, the OR will decline continuously
until menopause initiates at <1000 NGFs (Block, 1952;
Richardson et al., 1987; Gougeon et al., 1994; Hansen et al., 2008).
The changing dynamics of OR are the consequence of
two opposing processes that involve complex genetic and
environmental factors: the formation of new NGFs and the
recruitment of NGFs from the OR for maturation or atresia
(Kerr et al., 2013). During this scenario, newly formed NGFs are
maintained for various lengths of time during the reproductive
lifespan (Adhikari and Liu, 2009; Reddy et al., 2010).
In summary, the size of the human OR during life is not
constant. After a first prenatal step in which the OR is established,
the size of theOR is kept constant during an intermediate perinatal
step and then progressively decreases to values that no longer
support ovulation (Pelosi et al., 2015).
The life course of ovarian function once the OR is established
thus represents an unusual case in which aging has two
components. The usual stochastic decline of function and activity
seen in all physiological systems certainly occurs—as seen in the
progressive loss of quality of oocytes (Henderson and Edwards,
1968; Tarín et al., 1998); but the major force is the programmed
monthly recruitment of oocytes that progressively depletes the
OR. In other words, the decline in the size of the OR drives
reproductive aging (i.e., toward menopause). Menopause ensues
when regular recruitment decreases follicle numbers below a
threshold. This process is at least partially genetically determined.
Thus, although it has much sharper timing in a population of
women than other age-related declines, the dynamics of the
reserve and the timing ofmenopause can be changed bymutations
or environmental factors that alter the size of the initial reserve or
slow the rate of recruitment/atresia.
The effects of prenatal and postnatal environmental factors
on OR have recently been updated (Richardson et al., 2014), in
this review we consider the genomic factors that influence OR
dynamics during prenatal and postnatal life.
Studies have found many genes affecting OR: no single
dominant gene has been identified as responsible for the life
course of OR.We first consider the genomics of formation of new
NGFs with the establishment of the OR, and then turn to the
genomics of the recruitment of NGFs from the OR for maturation
and atresia. We reference available data on human instances of
reduced OR, and especially primary ovarian insufficiency (POI);
but the vast majority of studies have been performed on animal
models. There are obvious differences between the evolutionarily
distant rodent models and human—including the time scale,
the mouse estrus cycle, and some differences in gene usage
noted in the text below. Nevertheless, the available comparative
developmental and genetic data are consistent with very similar
overall formation and fate of the OR.
GENOMICS OF THE ESTABLISHMENT OF
THE OVARIAN RESERVE
In every mammalian species, the OR is formed during definitive
ovarian histogenesis, the last phase of ovary organogenesis
(Ottolenghi et al., 2004), by a coordinated series of processes
collectively referred to as follicular endowment (Hirshfield,
1991). NGF endowment begins with the formation, commitment,
migration, and colonization of the gonad by a founder population
of primordial germ cells (PGCs). After the development of the
bipotential gonad, and female sex determination (see She and
Yang, 2014), definitive ovarian histogenesis occurs, and the size
of the OR is consolidated during follicle formation, now called
follicular assembly (Skinner, 2005; Pepling, 2012).
Genes Involved in Formation, Migration,
and Gonad Colonization of PGCs
The somatic compartment and PGCs develop in different
microenvironments, correlated with their idiosyncratic identities.
During gastrulation—3 wpc in humans—a small population of
PGCs develops in the extra-embryonic compartment, specifically
at the base of the allantois in the endoderm of the dorsal wall
of the yolk sac (Ginsburg et al., 1990). Subsequently, PGCs start
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to migrate to their final destination, the gonad, a process that
is completed 6–7 wpc (Fujimoto et al., 1977; Kurilo, 1981). It
is during this migration that PGCs start to proliferate, and they
continue to multiply during the colonization of the gonad (Baker,
1963).
In mouse, the process is relatively compressed in its shorter
lifespan, with PGCs developing starting at E6.25, migrating at
E8.5, and completely installed in the genital ridges by E10.5
(Saitou and Yamaji, 2012).
Studies in the mouse have revealed some of the most critical
signals for PGC specification, migration and proliferation. PGC
specification is dependent on BMP signaling from the extra-
embryonic ectoderm (Pelosi et al., 2011). Indeed, in Bmp4 = 
embryos PGCs fail to complete migration, and Bmp4+=  ovaries
show a reduced or absent population of PGCs (Lawson et al.,
1999). Furthermore, deletion of other members of this family,
such as Bmp2 and Bmp8b, and of downstream mediators of
the BMP pathway like Smad1 and Smad5, produced similar
phenotypes (Ying et al., 2000; Chang andMatzuk, 2001; Tremblay
et al., 2001; Ying and Zhao, 2001). Subsequently, Blimp1
expression is required to maintain PGC identity and inhibit
differentiation into the mesodermal cell lineage (Ohinata et al.,
2005).
Germ cells express important survival factors very early during
and following their specification. They include the pluripotency-
related Oct4. Oct4 is necessary for embryo development and
the formation of the pluripotent inner cell mass (Nichols et al.,
1998). Conditional deletion of Oct4 in PGCs also resulted in
early apoptosis and resultant lack of germ cells in the adult ovary
(Kehler et al., 2004).
Nanos genes are also important for specification and migration
of PGCs. In Drosophila ablation of maternally-derived Nanos1
leads to failure of PGC migration (Kobayashi et al., 1996). By
contrast, deletion of mouse Nanos1 did not affect germ cell
development (Haraguchi et al., 2003; andNanos2 is expressed only
in male PGCs). However, ablation of Nanos3 caused defects in
mouse PGC migration and proliferation, leading to sterility in
both males and females (Tsuda et al., 2003).
Coordinated expression of Kit receptor and its ligand Kitl,
encoded at the white spotting (W) and steel (Sl) loci, respectively,
is indispensable for the survival, migration, proliferation, and
overall proper establishment of ovarian PGC for future follicle
assembly (Thomas and Vanderhyden, 2006). Kit is expressed
in mouse germ cells starting at E7.5 during their migration to
the ovary, while its ligand Kitl is expressed in somatic cells
along the migratory route (Besmer et al., 1993). Several mutant
alleles at the W or Sl loci have been described, and the type of
mutation determines the severity of the phenotype, ranging from
reduction of the number of PGCs reaching the gonad to reduced
developmental capability of the germ cells (Russell et al., 1948;
Reith et al., 1990; Buehr et al., 1993; Bedell et al., 1995). Themutant
steel panda at the Sl locus causes a pronounced decrease in the
size of the OR at birth, along with arrest of the remaining follicles
at the primordial stage (Huang et al., 1993). By contrast, the Wv
mouse variant, caused by a point mutation in the conserved ATP
binding domain, produces a phenotype reminiscent of POI in
women (Smith et al., 2012); the size of the OR in these mice is
severely compromised at birth and exhausted by 2 months, and
the mice display elevated gonadotropin levels, reduced estrogen
and progesterone levels, and decreased bone density (Smith et al.,
2012).
Factors involved in germ cell proliferation are also critical
for the formation and maintenance of the initial population of
germ cells. Pin1 affects cell cycle regulation, and its ablation
in mice caused fertility defects due to prolongation of the cell
cycle with resultant slower proliferation. The features included
diminished numbers of gonocytes and oocytes during embryonic
development (Atchison et al., 2003). Similarly, deletion of Pog,
which is involved in germ cell proliferation, led to sterility, with
a smaller pool of germ cells at birth and no follicles in the adult
ovary (Agoulnik et al., 2002).
Genes Involved in Definitive Ovarian
Histogenesis
Once the ovary has been formed and germ cells are committed
to the female fate, ovarian development moves to the last phase
of organogenesis (Ottolenghi et al., 2004), the definitive ovarian
histogenesis with establishment of the OR. This occurs with the
process of follicle histogenesis or follicular assembly (Pepling,
2012), starting about postnatal day 0 (P0, birth) inmice and before
13 wpc in human in the inner portion of the ovary, near the
rete ovarii (Kurilo, 1981; Gondos et al., 1986; Sforza et al., 2003;
Maheshwar and Fowler, 2008).
The solid cell mass of the bipotential gonad is progressively
cleaved into elongate formations of germinal and somatic cells
called “ovigerous cords” (Byskov, 1986).
The population of oogonia, derived from PGCs, expands
dramatically through a series of rapid mitotic divisions with
incomplete cytokinesis. This results in syncytial nests of oogonia
called “germ cell nests” or “germ cell cysts.” In the human fetal
ovary all oogonia display similar mitotic activity (Bendsen et al.,
2006) until about 10 wpc, and then the first oogonia enlarge
and become primary oocytes that initiate meiotic prophase I.
Preleptotene cells are found as early as 9–10 wpc (Kurilo, 1981;
Gondos et al., 1986; Bendsen et al., 2006).
Initially, meiosis is strikingly asynchronous, with more and
more germ cells initiating meiosis while some oogonia are still
expressing stem cell markers and continuing to proliferate until
at least 16 wpc (Baker, 1963; Skrzypczak et al., 1981; Kerr
et al., 2008). After the preleptotene stage, the primary oocytes
rapidly proceed through the subsequent stages of prophase of the
first meiotic division—i.e., leptotene, zygotene, and pachytene,
reaching diplotene and the “resting” or “arrested” stage at which
meiosis is blocked with the nucleus filled with decondensed
chromatin. This state is also called “dictyate.”
We next discuss genes and processes within the oocyte that act
in assembly of the primordial follicle pool.
Genes Involved in Germ Cell Survival, Meiosis, and
DNA Damage Repair
Study of an anti-apoptotic Bcl-x hypomorphic mouse model
showed that PGC migrated to the genital ridge by E12.5 but were
lost by apoptosis by E15.5, suggesting the importance of Bcl-x
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for germ cell survival (Rucker et al., 2000). However, deletion of
Bcl-x in postnatal oocytes did not affect the size of the OR or
growing follicles, so that its specific action is apparently limited
to embryonic development (Riedlinger et al., 2002).
In addition to apoptosis, autophagy is important in regulating
oocyte and follicle development. Ablation of either of two
autophagic factors, Atg7 and Becn1, led to comparable loss of
follicles by P1 (Gawriluk et al., 2011).
Connexin 43, encoded by Gja1, is one of the proteins forming
the gap junctions that permit passage of molecules between
cells in the ovigerous cords. The phenotype of Gja1 =  mice
is germ cell-specific and affects both sexes (Juneja et al., 1999).
The number of PGC is reduced in embryonic gonads starting
from E11.5, suggesting an indispensable function of connexins in
communication between cells during PGC development.
Duringmeiosis, germ cells undergoDNAdouble-strand breaks
for recombination that potentiates genetic diversity in progeny.
Mutations in genes involved in creation and repair of double-
strand breaks negatively impact fertility and lead to POI (Pelosi
et al., 2015). For example, Spo11 is required to induce double-
strand breaks during meiosis, and Spo1 =  female mice have a
smaller OR, with germ cell defects evident by E15.5 (Romanienko
and Camerini-Otero, 2000). Meiotic defects also result from
deletion of two other meiosis-specific genes. Premature loss of
mouse germ cells that was complete by P4 was seen in Msh4 = 
and by 2 months inMsh5 =  ovaries (de Vries et al., 1999; Kneitz
et al., 2000).
Among additional meiotic genes, Dmc1 encodes a protein
needed for DNA strand exchange, and its deletion in mice
also caused a reduction in mouse follicle numbers and follicle
attendant on failure of chromosome synapsis (Pittman et al.,
1998). Interestingly, bothMSH5 and DMC1 have also been found
associated with POI in women (Mandon-Pépin et al., 2008).
Defective mouse chromosome synapsis also ensued when Rec8,
a component of the cohesin complex, was ablated, causing loss of
follicles by P5 (Xu et al., 2005).
A vital factor in DNA damage checkpoint control during
meiosis is the ataxia telangiectasia mutated (Atm) gene, which is
activated following double-strand breaks. Deletion ofAtm inmice
led to loss of follicles by P11 and resulted in sterility (Barlow et al.,
1998). And in humans, ataxia telangiectasia, the loss-of-function
mutation of ATM, is associated with ovarian dysgenesis with
defects in PGCdevelopment (Miller andChatten, 1967). Failure of
crossover focus formation and generation of non-exchangemouse
chromosomes also occurred after ablation of Lsh, another factor
involved in the maintenance of genomic stability. Again, this led
to oocyte loss and lack of follicle formation (De La Fuente et al.,
2006).
Cdk2 is involved more generally in cell cycle progression. It has
nevertheless been found that Cdk2 is dispensable during mitosis,
but is critical for the completion of prophase I of meiosis, and
Cdk2 mutation caused complete germ cell loss by P2 (Ortega
et al., 2003). A similar sterile phenotype resulted from ablation
in mice of Cbep, which is involved in the regulation of the
synaptonemal complex. Cbep =  female mice were sterile and
contained only a few oocytes arrested in pachytene (Tay and
Richter, 2001).
Ablation of Brca1—involved in DNA damage detection and
repair, as well as cell cycle arrest—is embryonic lethal in mice
(Shen et al., 1998). However, Brca1 heterozygous mutant mice
survived, though with a reduced OR seen as early as P5;
by contrast, Brca2 heterozygous or homozygous ovaries were
indistinguishable from wild-type (Titus et al., 2013). Function
of DNA repair genes, including Brca1, was shown to decrease
with age, while double-strand breaks accumulated in mouse
and human oocytes. Women with BRCA1 mutations were also
reported to have lower OR, inferred from AMH levels (Titus
et al., 2013), but others observed no change in fertility or
OR (Kotsopoulos et al., 2008; Moslehi et al., 2010; Pal et al.,
2010; Valentini et al., 2013; Michaelson-Cohen et al., 2014).
Understanding the role of BRCA1/2 in menopause or POI is
complicated by the lack of standardization in various studies,
which assessed fertility or OR with various methods. In addition,
several reports had few participants and stratification was not
always the same. Also, the association between BRCA1/2 and
fertility may depend on other factors, even though several studies
have reported earlier menopause or low OR in BRCA carriers
(Rzepka-Górska et al., 2006; Oktay et al., 2010; Finch et al., 2013;
Lin et al., 2013;Wang et al., 2014a). As one specific possible source
of discrepancies in study results, BRCA1/2 effects may be smaller
in younger women and become more clinically evident in those
approaching perimenopause (an age cohort that was not included
in several of the studies).
Mutations in the Fanconi anemia complex of DNA damage
genes are also implicated in the control of OR. Deletion of Fanca
inmice led to reduced fertility and sterility by 21 weeks of age with
the total depletion of ovarian follicles (Cheng et al., 2000). A very
similar phenotype was also found in Fancc =  mice (Whitney
et al., 1996); and deletion of Fancg caused comparable infertility
at 21 weeks of age with a dramatic reduction in the OR (Koomen
et al., 2002).
Heat shock proteins have additional functions in meiosis
completion and oocyte development. Hsf1 is a maternal effect
transcription factor affecting the expression of several heat shock
proteins includingHsp90a,Hsp25,Hsp70.1, andHsp105 (Metchat
et al., 2009). When it was deleted in mice, meiotic defects in
oocytes ensued, characterized by delayed G2/M transition, partial
block of germinal vesicle breakdown, and asymmetrical division.
Furthermore, Hsf1 was required for embryonic development,
eliciting a protective response against oxidative stress in the oocyte
(Bierkamp et al., 2010).
Finally, mutations in several other meiotic genes have also
been identified as associated with POI in humans. Caburet et al.
(2014) demonstrated mutations in STAG3 (cohesin)—thought to
be involved in sister chromatid association—in a large pedigree
evincing POI (“POF8” in OMIM 615723), and mice ablated for
the gene were sterile. Mutation in the X-linked gene, POF1B,
encoding a protein that interacts with actin filaments, causes
“POF2B” (OMIM 300604; Lacombe et al., 2006); the authors
hypothesized that POF1B could also function in the pairing
of meiotic chromosomes, and alteration in its function could
lead to drastically fewer oocytes being created. Wang et al.
(2014b) found another meiotic gene, HFM1, mutated in two
sisters with POI, and in another case among 69 analyzed
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FIGURE 1 | Morphogenesis of follicles from the arrival of primordial germ cells (PGC) in the nascent ovary to secondary follicles. Genes assigned to
each transition are as specified in the text. Somatic genes are shown in blue; germ cell genes are shown in pink; and genes that are either expressed in both or
whose site of expression has not been assigned are in gray. In the ovigerous cord, oocytes that are lost and do not form primordial follicles are colored gray.
(“POF9” in OMIM 615724). Mutation in SYCE1, essential
for formation of the synaptonemal complex, can account for
autosomal recessive POI in another family (de Vries et al.,
2014).
Genes Involved in Follicular Assembly
During the progression to the dictyate state, the ovigerous cords
are carved into clusters of germinal and somatic cells that give rise
to the NGFs (Zamboni et al., 1980). The nascent NGFs emerge
when the intercellular bridges between primary oocytes inmeiotic
prophase I break down while single oocytes become closely
surrounded by a squamous layer of pre-granulosa cells. Outside
the pre-granulosa layer a basement membrane encompasses and
demarcates each newly formed NGF.
Notably, assembly of a limited number of NGFs is accompanied
by the degeneration of all the other oocytes in the clusters
of cells surrounded by the squamous pre-granulosa cells and
the basement membrane (Figure 1). More than 85% of germ
cells degenerate, and it remains unclear whether there is
specific selection for specific oocytes; whether the selection is
random; whether those destroyed have any function in the
process; or whether there may be insufficient auxiliary cells to
support formation of more than a smaller number of follicles.
Additionally, it is still unknown if the discarded oocytes provide
any “nourishment” to surviving germ cells, as in Drosophila
(reviewed in Pelosi et al., 2015). Nonetheless, several genes are
known to be involved in the regulation of this process, and
mutations in those genes have significant repercussions for the
OR, as follows.
Figla is an oocyte-specific transcription factor required for
primordial follicle formation (Soyal et al., 2000).When it is ablated
in mice, oocytes fail to form follicles and eventually die soon
after birth, leaving female but not male animals sterile. Figla is
also important inmaintaining femaleness and suppressing ectopic
expression of male genes (Hu et al., 2010). It has been shown
to directly regulate the expression of Zp1, Zp2, and Zp3, which
encode the corresponding glycoproteins of the extracellular zona
pellucida (Liang et al., 1997). Human FIGLA is also expressed
in the oocytes of primordial follicles, suggesting a conserved
function. Indeed, FIGLA mutation is a cause of POI in several
Chinese POI patients (Zhao et al., 2008; “POF6” in OMIM
612310).
Also involved in primordial follicle formation, follistatin is
involved in germ cyst breakdown and oocyte apoptosis. Mice
expressing only a short isoform of follistatin displayed a largerOR,
resulting from a reduction in germ cell apoptosis during germ cyst
breakdown and a prolonged duration of the breakdown process
itself (Kimura et al., 2011). However, these mice later lost the
initial population of primordial follicles more rapidly than wild-
type counterparts, so that other isoforms are likely required for the
correct formation or maintenance of the OR.
The Notch signaling pathway is also implicated in the
formation of the OR. Although mutations of various members
of this family are embryonic lethal in mice (Conlon et al., 1995;
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Hrabĕ de Angelis et al., 1997; Jiang et al., 1998b; Xue et al.,
1999; McCright et al., 2001), ovary cultures in which Notch
signaling was disrupted by g-secretase inhibitors contained fewer
primordial follicles, withmore of the oocytes persisting within the
germ cysts (Trombly et al., 2009).
Neurotrophins, a family of growth factors involved in
cell survival and development, are also activated in ovary
development. Nerve growth factor (Ngf ), its receptor (Ntrk1),
and a related receptor (Ntrk2) have all been found to affect mouse
primordial follicle formation. Ngf =  or Ntrk1 =  ovaries
showed a larger population of oocytes still inside germ cell cysts,
and only a few primordial follicles were formed (Dissen et al.,
2001; Kerr et al., 2009). In addition, neurotrophins Nt4 and Bdnf
are likely involved in follicular assembly and/or survival, because
germ cell death was increased in cultures when signaling was
blocked (Spears et al., 2003). Still another neurotrophin, Nt3, and
its receptor Ntrk3 also seem important for oocyte survival, and
affect the transition of follicles from primordial to primary stage
(Nilsson et al., 2009).
At the level of turnover of follicles, deletion of genes belonging
to the apoptotic pathway also influenced the size and dynamics of
the OR. Casp2 =  mouse ovaries had more primordial follicles
at P4, and germ cells were resistant to cell death following
chemotherapy (Bergeron et al., 1998). Ovaries frommice in which
the anti-apoptotic Bcl2 was ablated showed a reduced number of
primordial follicles, with little or no significant effect on growing
follicles (Ratts et al., 1995). Roughly one third of primordial
follicles were aberrant, with a single layer of cuboidal granulosa
cells but without any oocyte within. However, morphometric
analysis was done on adult ovaries, and no data on the initial size
or theORwas provided. Thus it is unclear whetherBcl2 is involved
in germ cyst breakdown, oocyte survival during primordial follicle
development, or both.
Deletion of the Bcl2-associated X protein (Bax), resulted in
the formation of a larger mouse OR. Bax =  ovaries contained
larger numbers of PGC during embryonic development, and had
more primordial follicles than wild-type ovaries at P4 (Greenfeld
et al., 2007). Although this contradicted a previous study (Perez
et al., 1999; see below), it was inferred that the phenotype of
increased follicular endowment was due to BAX regulation of
PGC survival or proliferation during migration to the developing
gonad (Greenfeld et al., 2007).
It should be noted that deletion of Ahr—a positive regulator of
Bax (Matikainen et al., 2001)—produced mouse ovaries with no
change during embryonic development (E18.5) but an increased
population of primordial follicles at P2–P3 (Benedict et al., 2000).
The number of primordial follicles returned to normal by P8
and remained very similar to wild-type until at least P32–P35.
However, by P53 Ahr =  ovaries had fewer antral follicles,
suggesting an action of AHR and BAX in follicle maturation as
well as in primordial follicle endowment (Benedict et al., 2000).
Deletion of another apoptotic gene, Mcl1, caused a reduction
in the OR that was significant as early as P7 and was almost
total within 3 months. Mcl1 =  oocytes displayed elevated
mitochondrial dysfunction with elevated superoxide levels, and
also showed chromosome abnormalities, all of which could
plausibly activate the autophagic pathway (Omari et al., 2015).
A very different class of factors affecting formation of the
OR comprises retrotransposable elements and their expressed
genes. Overexpression of L1 led to significant increase in oocyte
loss during NGF endowment, thus affecting the size of the
OR (Malki et al., 2014). Interestingly, oocyte survival was
recovered by treatment with the reverse transcriptase inhibitor
AZT, demonstrating the specific action of L1 retrotransposons
(Malki et al., 2014). The involvement of retrotransposons in
germ cells and follicle dynamics could be more prevalent than
generally thought. In human oocytes, there is some evidence of
retrotransposon expression (Georgiou et al., 2009), and more
studies are warranted, especially given the potential relevance for
development and disease.
GENOMICS OF FOLLICULOGENESIS
In the overall process, once they are formed, NGFs can remain
quiescent in mice for up to 18 months and in women for
decades—or not even be used at all during reproductive life.
They may undergo atresia before recruitment, or may instead
be selected for maturation that will lead to the ovulation
of one dominant oocyte competent for fertilization at each
menstrual cycle. But the majority of assembled NGFs simply
survive for long periods of time. If NGF dormancy is lost
or they are damaged, follicular endowment is depleted by
activation or death, respectively. This results in premature female
reproductive aging and POI. One can therefore envisage two
types of interventions that help to maintain the OR: (a) the
maintenance of NGF quiescence and survival, and (b) the
suppression of NGF activation (Adhikari and Liu, 2009; Reddy
et al., 2010). Operationally the distinction is difficult, but stages
in folliculogenesis can be discriminated, with many steps between
the NGFs and the preovulatory or Graafian follicles, and those in
turn can either ovulate their constituent eggs for fertilization or be
lost by atresia.
Two events dominate folliculogenesis both in mouse and
in human (Monniaux et al., 1997; McGee and Hsueh, 2000).
In an initial step, NGFs are continuously recruited from OR
(continuous recruitment) for their subsequent development until
they have entered the antral cavity. In a successive step a few of
the antral follicles are cyclically rescued to reach the preovulatory
stage (cyclic recruitment).
In continuous recruitment the transition from primordial
to primary follicles, termed follicle activation, results in
morphological and physiological changes in both the germ and
somatic cells. The volume of oocytes increases greatly, and the
flattened pregranulosa cells surrounding the oocytes differentiate
and proliferate into cuboidal granulosa cells. After activation
follicles grow slowly (basal follicular growth), their growth rate
tightly related to proliferation of granulosa cells. Most of the
activated follicles undergo atresia.
In cyclic recruitment, in contrast, follicular growth is rapid and
occurs by enlargement of the antrum (terminal follicular growth).
In women, as in all mono-ovulatory species, only one of these
follicles, the “dominant follicle,” is usually selected for ovulation
of a fully competent oocyte every cycle, while the subordinate
selected antral follicles are discarded by atresia.
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Continuous recruitment with basal follicular growth is mainly
under the control of growth factors of paracrine origin, and
is gonadotropin-independent—though follicle-stimulating
hormone (FSH) may exert an indirect mitogenic effect on
granulosa cells by enhancing expression of growth factors or
growth factor receptors. In contrast, cyclic recruitment with
terminal follicular growth is strictly gonadotropin-dependent.
FSH plays determinant roles in enhancing granulosa cell
differentiation and survival. These actions are again mediated or
modulated in an important way by paracrine factors, particularly
steroids and growth factors. Luteinizing hormone (LH) stimulates
steroidogenesis in theca cells and sustains terminal maturation of
granulosa cells in pre-ovulatory follicles.
In the human ovary continuous recruitment begins early in
prenatal life. Instead, cyclic recruitment occurs only after puberty.
Primary follicles have been observed in 17-week old XX fetuses
(Kurilo, 1981). By 23–26 wpc pre-antral follicles are also present,
and after 35 weeks all follicle stages, primary to antral, can be
observed (van Wagenen and Simpson, 1965; Sforza et al., 1993).
Genes Involved in the
Gonadotropin-Independent Phase
Based on both human studies andmousemodels, factors involved
in the transition from primordial to primary follicles include
SOHLH1/2, NOBOX, LHX8, KIT, YBX2, and FOXO3—all
expressed in the oocytes—and KITL and FOXL2, expressed in
the granulosa cells. Signaling from other cell lineages may also
influence NGF quiescence or recruitment, but specific actions are
less studied.
One of the most powerful factors is Foxl2, which acts
critically in several processes, including sex determination, ovary
development andmaintenance of gonadal femaleness. In humans,
mutation of FOXL2 causes Blepharophimosis/Ptosis/Epicanthus
Inversus syndrome (BPES), characterized by eyelid anomalies
and POI (Crisponi et al., 2001). Foxl2 is never expressed in
the testis, and is turned on specifically in granulosa cells of the
ovary at the time of sex determination. When Foxl2 is ablated
in female mice, granulosa cells in the ovary undergo partial sex
reversal, characterized by expression of male specific markers
including testis-determining Sox9. Joint ablation of Wnt4 and
Foxl2 drives sex determination more decisively toward the testis
fate during embryonic life, causing sex reversal that now extends
to germ cells (Ottolenghi et al., 2007). Foxl2 also acts negatively on
expression of Cyp26b1 and Sf1, which are required for male sex
determination (Kashimada et al., 2011a; Takasawa et al., 2014).
Furthermore, FOXL2 cooperates with BMP2 in regulating the
correct expression of follistatin, which in itself is also required
for female sex determination and ovary development (Kashimada
et al., 2011b). Foxl2 ablation causes primordial follicle failure in
progression to the primary stage, resulting in female sterility,
while the steroidogenic profile resembles that of testis, with the
up-regulation ofAmh and Cyp11a1 and the inhibition of Cyp19a1
(Uda et al., 2004;Ottolenghi et al., 2007). Foxl2 expression remains
obligatory throughout the entire reproductive lifespan (Garcia-
Ortiz et al., 2009). Indeed, when Foxl2 is ablated in the adult ovary
the somatic compartment comprising granulosa and theca cells
transdifferentiate to Sertoli-like and Leydig-like cells (Uhlenhaut
et al., 2009).
Sohlh1 and Sohlh2 share a similar function in germ cells, and
their ablation in mice results in the impairment of the transition
from primordial to primary follicles, with subsequent premature
follicle loss (Pangas et al., 2006; Choi et al., 2008a). Sohlh1 has
been shown to directly regulate Lhx8 (Pangas et al., 2006), a
transcription factor involved in oocyte survival; its deletion in
mice also causes rapid oocyte loss (Choi et al., 2008b).When Lhx8
is ablated, primordial follicles fail to progress to the primary stage
and soon degenerate, leaving the ovary empty by P7 (Choi et al.,
2008b). Lhx8 directly affects expression of the homeobox gene
Nobox (Park et al., 2012), another transcription factor that seems
required for the transition to primary follicles. Nobox =  mouse
ovaries appear very similar to their wild-type counterparts.
However, the oocytes are developmentally impaired, with
many germ cell cysts still present at P3 in Nobox =  ovaries;
progression beyond the primordial stage is blocked, and follicles
are nearly completely lost by P14 (Rajkovic et al., 2004).
Because these genes—Sohlh1 and Sohlh2, Lhx8, and
Nobox—belong to the same regulatory pathway, the similarities
in phenotype when they are ablated are not surprising. Several
of them have also been associated with POI in women. LHX8
was not found changed in any of a cohort of Caucasian patients
(Qin et al., 2008); and SOHLH1 mutations or variants have not
been evaluated, so that there may be a failure of ascertainment
in that case. By contrast, eleven variants in the oocyte gene
SOHLH2, including four mutations detrimental to its function,
have been found associated with POI (Qin et al., 2014). As
for NOBOX (“POF5” in OMIM 611548), it was first shown to
be mutated in 1 of 96 POI cases analyzed (Qin et al., 2007).
Strikingly, sequencing of NOBOX in a cohort of 178 women
with POI found mutations in 12 (6.2%), and lesions in NOBOX
may thus be a substantive cause of POI at a population level.
All the characterized mutations compromised binding to the
GDF9 promoter (Bouilly et al., 2011), which would indeed arrest
development. Other studies have reported deletions of NOBOX
associated with POI (Rossi et al., 2008; Sehested et al., 2010).
Ybx2, also known as Msy2, is a germ cell-specific factor
encoding a DNA/RNA binding protein. When mutated, it causes
infertility in both male and female mice, likely due to instability
of cytoplasmic transcripts (Yu et al., 2001). Ablation of Ybx2
in the ovary results in follicle loss starting at around 3 weeks,
accompanied by anovulation and absence of cumulus cells (Yang
et al., 2005).
Foxo3 is a potent transcription factor involved in follicle
activation. In the mouse ovary, Foxo3 is expressed exclusively
in the oocytes of primordial and early growing follicles. FOXO3
is regulated by phosphorylation of AKT, which induces its
translocation to the cytoplasm and therefore effectively blocks
its nuclear function (John et al., 2008). When Foxo3 is ablated
in mice, all the primordial follicles start growing uncontrollably
and the ovary becomes void of follicles by 15 weeks (Castrillon
et al., 2003). It has been shown that Galt1 is a downstream
target of Foxo3. Prolactin signaling through the short form of its
receptor causes Foxo3 down-regulation, and consequently Galt1
repression, again leading to accelerated follicle recruitment and
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POI (Halperin et al., 2008). This is of particular interest because
human GALT deficiency causes galactosemia, another cause of
POI (Pelosi et al., 2015; OMIM 230400).
Because of its function in controlling the OR dynamics, lesions
in the human FOXO3 seem a plausible candidate to cause POI.
However, studies in women have been inconclusive (Gallardo
et al., 2008), consistent with the finding that FOXO3 does not seem
to be expressed in human oocytes (Tarnawa et al., 2013). In fact,
FOXO3 has been found reported to be expressed in granulosa cells
rather than oocytes in human ovaries, where instead FOXO1may
take over its function (Tarnawa et al., 2013). Conversely, Foxo1
is expressed in mouse somatic cells but not oocytes, suggesting
a differentially evolved mode of regulation between human and
mouse ovaries.No involvement ofFoxo1 in POI has been reported,
but thismay rather reflect the widespread requirement for FOXO1
action in many tissues.
One might anticipate that other factors belonging to the
PI3K/AKT pathway might participate in controlling size of the
OR. Indeed, one of these factors,Pten, encodes a lipid phosphatase
that negatively regulates PI3K, and is also involved in setting
the rate of follicle activation in mice: oocyte-specific deletion of
Pten again leads tomassive primordial follicle recruitment (Reddy
et al., 2008). However, as with FOXO genes, changes in PTEN have
at least as yet not been found in human POI (Shimizu et al., 2009;
Zhao et al., 2011).
Quiescence of primordial follicles is further regulated by a
complex of TSC1 and TSC2, which act by inhibiting the activity
of mTOR complex1. Deletion of Tsc2 in mouse oocytes caused
increased mTOR activity followed by accelerated recruitment
of the OR starting by P23 and follicle depletion by 4 months
(Adhikari et al., 2009). A similar POI-like phenotype was also
observed in mice with oocyte-specific deletion of Tsc1 (Adhikari
et al., 2010). Interestingly, double knock-out of Tsc1 and Pten
enhanced the effect on follicle recruitment compared to single
gene mutants (Adhikari et al., 2010). These results suggest an
additive effect between Tsc1 and Pten, consistent with overlapping
functions of the mTOR and AKT pathways in regulating the
dynamics of the OR. Notably, another factor involved in both
mTOR and AKT signaling is PDK1, and oocyte-specific deletion
of Pdk1 again caused accelerated mouse follicle loss, consistent
with a role for this gene as well in follicle survival (Reddy et al.,
2009). Moreover, the authors suggested a model in which PDK1
activity lies at the decision point between loss and activation of
the OR.
P27KIP1 also participates in maintaining NGFs in a quiescent
state. In p27kip1 =  mice, primordial follicles were prematurely
recruited and subsequently lost, causing POI comparable to that
seen in Foxo3 =  ovaries (Rajareddy et al., 2007). However,
it was shown that P27KIP1 and FOXO3 acted independently.
In addition, unlike Foxo3, p27kip1 is expressed in both oocytes
and granulosa cells of primordial and growing follicles, thereby
affecting proliferation and survival of granulosa cells as well
(Rajareddy et al., 2007).
Hippo signaling provides still another pathway inhibiting
follicle recruitment (Kawamura et al., 2013). This pathway is
characterized by the action of MST1 and MST2—orthologous
to Hpo (Hippo) in Drosophila—which along with SAV1,
phosphorylate LATS1/2. That leads to further phosphorylation
and later degradation of YAP and TAZ, and results in
suppression—or at least limitation—of follicle recruitment.
When Hippo signaling is disrupted in mice, YAP and TAZ are
active and interact with TEAD transcription factors, activating
transcription of downstream target genes including Ctgf and
Naip (Kawamura et al., 2013). CTGF is involved in follicle
development, and Ctgf =  mice were subfertile, had decreased
ovulation rates, and increased apoptosis of granulosa cells
(Nagashima et al., 2011). Furthermore, statistically significant
copy number variations of NAIP, which is involved in inhibition
of apoptosis, were found in POI patients of Caucasian origin
(Aboura et al., 2009).
Two genes acting upstream in the Hippo pathway,DIAPH2 and
DIAPH3, were also found associated with menopause. Castrillon
and Wasserman (1994) had identified the dia locus in Drosophila
by screening for male sterility mutations, and found alterations in
cytokinesis associated with mutated dia alleles. In women, the X-
linked gene DIAPH2 was disrupted by a breakpoint in a family
with POI (“POF2A,” OMIM 300511; Bione et al., 1998), and more
recently variants in the gene were also found associated with the
regulation of the age of menopause (He et al., 2010). Variants of
DIAPH3 have now been reported associated with both timing of
menopause and size of the OR (Schuh-Huerta et al., 2012).
Amh—another member of the TGFb superfamily—starts to
be produced in granulosa cells of mouse follicles starting at the
primary stage (Durlinger et al., 2002a). In Amh =  ovaries, the
number of growing follicles was larger than control, whereas
depletion of primordial follicles became significant by 4 months
of age (Durlinger et al., 1999). When neonatal ovaries were
cultured in vitro in presence of AMH, growing follicles were
reduced by 40–50% after 2 and 4 days (Durlinger et al., 2002b).
In addition, when preantral follicles were cultured in presence of
AMH, FSH-induced follicle growth was inhibited. A similar result
was obtained when Amh =  mice were treated with FSH: follicle
recruitment was greater than in wild-type females (Durlinger
et al., 2001). These results confirm a dual role for AMH: during
gonadotropin-independent recruitment it inhibits the transition
from the primordial to the primary stage, whereas in the gona-
dotropin-dependent phase it antagonizes responsiveness to FSH.
Follicle recruitment as well as folliculogenesis are dominated by
communication between oocyte and granulosa cells.
Two important oocyte factors involved in follicle growth are
Gdf9 and Bmp15, both members of the transforming growth
factor beta superfamily. They are 52% homologous and have
similar functions, primarily involved in the progression of follicle
maturation (Yan et al., 2001).
Gdf9 is necessary for fertility, because its ablation in mice
causes a block in follicle growth at the primary stage (Yan
et al., 2001). Additionally, Gdf9 actively induces granulosa cell
proliferation; formation of the theca layers and promotion of
androgen biosynthesis from theca cells (Solovyeva et al., 2000);
and expansion of the cumulus cells. Hence it is actively involved in
the communication between the oocyte and surrounding somatic
cells (Dong et al., 1996; Elvin et al., 1999).
By contrast, Bmp15 ablation in mouse does not result in
infertility. However, mice are subfertile, have a reduced litter size,
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and display impairment of ovulation and fertilization, suggesting
a prevalent role of Bmp15 in the peri-ovulatory period (Yan et al.,
2001).
Interestingly, Gdf9 and Bmp15 both appear to be involved
in the breakdown of ovigerous cords as well, because mouse
mutant ovaries showed significant numbers of follicles containing
multiple oocytes (Yan et al., 2001).
Mutations in GDF9 have also been associated with POI in
several populations, including missense mutations in a cohort
of Indian patients (Dixit et al., 2005) as well as POI cases of
Caucasian, Chinese, and African origin (Laissue et al., 2006;
Kovanci et al., 2007; Zhao et al., 2007). BMP15, an X-linked
gene, has also been associated with a substantial number of
instances of POI (“POF4” in OMIM 300510). Rossetti et al.
(2009) screened 300 unrelated idiopathic overtly POI women
and identified six non-synonymous BMP15 variants in 29 of
them. Other reports have noted additional associated mutations
in BMP15 (Di Pasquale et al., 2004; Dixit et al., 2006; Laissue et al.,
2006).
A member of the connexin family, connexin 43, is directly
involved in cell-cell communication and is necessary for the
correct development of growing follicles. Although ovaries from
Cx43 =  mice seemed grossly similar to wild-type up to several
weeks after birth, growing follicles failed to complete maturation
to the Graafian stage. In addition, mutant ovaries showed
premature luteinization, and oocytes were likely impaired in
completing meiosis to achieve competence.
Related to the interplay between oocyte and somatic cells,
growth factor Rspo2 is also involved in folliculogenesis, and
particularly in inducing the development from primary follicles to
more advanced developmental stages (Cheng et al., 2013). RSPO2
is produced by the oocyte from the primary stage onward, and
functions both in vitro and in vivo as a paracrine factor able to
stimulate follicle maturation. Additionally, when human cortical
cubes where transplanted into the kidney capsule of immune-
deficient mice, RSPO2 treatment was effective in promoting the
transition of human primary to secondary follicles (Cheng et al.,
2013). Interestingly, a mouse model hypomorphic for Rspo2
showed that in addition to skeletal malformations, females had a
reduced reproductive lifespan resembling POI (Bell et al., 2003).
However, RSPO2 function in humans still remains to be assessed,
and thus any association with POI is not known.
Genes Involved in the
Gonadotropin-Dependent Maturation
Phase
Maturation occurs with the integration of extra-ovarian signals
and intra-follicular factors to determine whether an antral follicle
will continue to develop or be diverted into atretic pathways.
Cyclic follicular recruitment is characterized by induction
of expression of mRNAs encoding a range of steroidogenic
enzymes, gonadotropin receptors, and local regulatory factors.
FSH provides the primary extra-ovarian driver for cyclic
follicular recruitment, and LH (lutropin) is required for further
development of follicles to the pre-ovulatory stage. FSH acts
through membrane-associated granulosa cell receptors (FSHR)
to stimulate granulosa cell proliferation and differentiation. The
most responsive follicle at the beginning of the cycle is the first to
produce estrogen and express LH receptor (LHR) on granulosa
cells.
Follicle-stimulating hormone production is itself regulated
by inhibin a (Inha), a glycoprotein member of the TGFb
superfamily (Vale et al., 1986). Inhibins are considered among
the biomarkers of OR in predicting human reproductive lifespan
(Steiner, 2013). Inha =  mice are infertile due to compromised
follicular development and the formation of mixed tumors of
granulosa and theca or undifferentiated stromal cells (Matzuk
et al., 1992). After screening patients with POI or primary or
secondary amenorrhea, Dixit et al. (2004) found a missense
mutation in INHA associated with POI, though no associated
variants were found in INHBA or INHBB. Confirming the positive
finding, other reports have also found mutations and variation of
INHA involved in POI in several populations (Shelling et al., 2000;
Marozzi et al., 2002; Harris et al., 2005; Woad et al., 2009).
Disruption of the inhibin-activin-follistatin pathway also
occurs in Taf4b =  female mice (Freiman et al., 2001). TAF4B
is a subunit of transcription factor TFIID, which participates
with RNA polymerase II, and was found specifically expressed in
ovarian granulosa cells. Taf4b =  mice were sterile, and mutant
ovaries showed a sharp decrease in numbers of growing follicles
and failure of oocytematuration and/or fertilization.No follow-up
has reportedwhether TAF4B affects the transcription of a targeted
subset of genes.
Follicle-stimulating hormone is also a predictor of reproductive
lifespan, controlling development of follicles to the antral stage, as
shown by targeted mutation of Fshb in mice (Kumar et al., 1997).
Furthermore, the same phenotype was observed by disruption of
the FSH receptor, confirming the importance of this signaling
pathway for the completion of folliculogenesis (Dierich et al.,
1998). Missense mutation in FSHR associated with POI has been
reported in Finnish patients (Aittomaki et al., 1995; Jiang et al.,
1998a; Doherty et al., 2002). However, some FSHR variants have
been found in both POI cases and controls (Sundblad et al., 2004),
and mutations causative of POI are rare (Layman et al., 1993; da
Fonte Kohek et al., 1998). Variants in FSHB were nevertheless
found associated with age of menopause in Caucasian women (He
et al., 2010), and one of those single nucleotide polymorphisms
was reported associated with age of menopause in women of
African origin as well (Spencer et al., 2013).
FSH increases the expression in mouse granulosa cells of C-
type natriuretic peptide (CNP)—encoded by the Nppc gene—but
not its receptor NPRB (Sato et al., 2012). Unlike FSH signaling,
which is mediated mainly through cAMP, CNP uses cGMP
specifically as second messenger (Sato et al., 2012). In Nppc and
Nprb hypomorphicmice, meiotic arrest was reversed prematurely,
and although ovulation occurred seemingly normally, female
mice were unable to deliver offspring. These results suggested the
importance of CNP/NPRB signaling for correct and synchronized
maturation of oocytes and cumulus cell differentiation from
granulosa cells (Zhang et al., 2010; Kiyosu et al., 2012). In addition
to skeletal defects and survival problems, Nprb =  mice also
showed arrest of ovarian follicles at the pre-antral stage (Tamura
et al., 2004).
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The LH signaling pathway is responsible for inducing ovulation
and luteinization through the coordinated cooperation of theca
and granulosa cells. LH stimulates theca cells to produce
androgens, which are then converted into estradiol by the
granulosa cells (Pelosi et al., 2015). Consequently Lh =  mice are
infertile, and mutant females show degenerating antral follicles
and an absence of corpora lutea (Ma et al., 2004). In addition,
levels of estrogen and progesterone were lower than in wild-type
mice. Confirming the hormonal basis of the phenotypes, Lh = 
mice can be rescued by chorionic gonadotropin administration.
Lhr =  mice are comparably infertile, and ovaries contained
follicles only up to the early antral stage, with no corpora lutea and
elevated LH (Zhang et al., 2001). In humans, a variant has been
found associated with the timing of menopause (He et al., 2010).
In granulosa cells, the surge of LH ultimately leads to the
activation of downstream factors including RAS, ERK1/2, and
EGFR.When a constitutively active form ofKraswas expressed in
granulosa cells, transgenic mice showed impairment of ovulation,
decreased ERK1/2 activity, and elevation of Protein kinase B,
PKB (AKT) function. The result in the mice was subfertility and
POI (Fan et al., 2008). Disruption of Erk1/2 in granulosa cells
itself caused female infertility due to ovulation failure; and it was
further shown that Erk1 and Erk2 are required for the LH-induced
resumption of meiosis in oocytes and the attendant ovulation and
luteinization (Fan et al., 2009).
C/EBPb, a downstream mediator of Erk1/2, is also important
in the response to the LH surge. Indeed, deletion of Cebpb in
mouse granulosa cells caused subfertility, whereasCebpa/b double
knock-outs were sterile. Cebpa/b =  ovaries failed to ovulate
and were devoid of corpora lutea, indicating the importance of
Cebpa and Cebpb in regulating the terminal differentiation of
granulosa cells during the luteinization process (Fan et al., 2011).
Targeted disruption of Egfr in granulosa cells caused impaired
oocyte meiotic resumption and impaired cumulus expansion,
with reduced ovulation and fertility (Hsieh et al., 2011); the LH-
induced activation of ERK1/2, p38MAPK, and connexin-43 was
also impaired.
Estrogen signaling is also critical for folliculogenesis and repro-
duction. Disruption of the estrogen receptor gene in mice caused
infertility; arrest of folliculogenesis with absence of corpora lutea;
and absence of mating behavior that was not restored even with
estrogen supplementation (Lubahn et al., 1993). Additionally,
deletion of Esr1? in theca cells resulted in premature loss of mouse
fertility similar to POI (Lee et al., 2009). In fact, polymorphisms
of ESR1 in women have been found associated with POI and
idiopathic infertility (Bretherick et al., 2008; Yoon et al., 2010; Du
et al., 2011; Cordts et al., 2012; M’Rabet et al., 2012).
Other Genes Involved in Folliculogenesis
Variants in still other genes have been found causative of POI, but
their involvement in ovarian development has not yet been studied
extensively. Duncan et al. (2012) reviewed 13 cases ofmutations in
POLG, the mitochondrial DNA polymerase, that were associated
with POI—and frequently also with neurological symptoms and
male infertility. Current data indicate that POLG variants can
also affect the timing of normal menopause (Stolk et al., 2012;
Shen et al., 2013). One study found no association (Bonomi et al.,
2012), but examined only a small number of cases. As another
example, Clast4 is highly expressed in mouse oocytes during
follicle maturation, but its function is still poorly understood
(Villaescusa et al., 2006). However, dominantly inheritedmutation
of its human ortholog—protein initiation factor 4E nuclear import
factor 1 (EIF4ENIF1)—was inferred as causative of POI in a
3-generation family (Kasippilai et al., 2013).
Although endocrine disorders, including hypothyroidism,
adrenal insufficiency, and hypoparathyroidism, all affect the
hormonal profile required for fertility, only a few POI cases have
been associated with mutations in genes of the endocrine system.
Most suggestively, NR5A1 (Steroidogenic factor Sf1), a gene
involved in gonadal differentiation and steroidogenesis (Tremblay
and Viger, 2003; Takasawa et al., 2014), is mutated in “POF7”
in OMIM 612964. Lourenco et al. (2009) identified missense,
frameshift, and in-frame mutations in NR5A1 in families with
anomalies of ovarian development and function, and in 2 of 25
sporadic cases of POI.
As for other endocrinological genes, Bhangoo et al. (2007)
reviewed cases of females with deficiency in the steroidogenic
acute regulatory (STAR) protein who showed recessive steroidal
hormone and adrenal insufficiency leading to POI. Zangen et al.
(2011) attributed POI in a case of Arab Palestinian origin to
mutation in PSMC3IP, abolishing co-activation of estrogen-
driven transcription. In another study, no mutations of PSMC3IP
were found in Swedish POI patients (Norling et al., 2014), but
ascertainment in such studies is often limited by small numbers
of patients and the large number of known “POI” genes.
NON-CODING RNAS
As in other physiological systems, it is increasingly evident that
small non-coding RNAs are essential in the regulation of ovarian
physiology. The classes expressed in the ovary include piwi
interacting RNAs (piRNAs); small interfering RNAs (siRNAs);
microRNAs (miRNAs); and long non-coding RNAs. We cannot
comment on analyses of lncRNAs in the dynamics of the
OR, because systematic studies have not yet been reported. It
is currently believed that piRNAs are required primarily for
mammalian male spermatogenesis rather than oocyte or ovary
development. Several mouse models showed important roles of
piRNAs in the male germline (Deng and Lin, 2002; Kuramochi-
Miyagawa et al., 2004; Aravin et al., 2007; Carmell et al.,
2007). Instead, despite known functions in oogenesis in lower
organisms (Thomson and Lin, 2009), a study in female mice
showed that deletion of a piRNA interacting protein had no effect
on female germline development (Kuramochi-Miyagawa et al.,
2004). Consistent with these findings, Dicer 1 (see below) affects
ovarian function, but is required for siRNAs andmiRNAs, and not
for piRNA formation. Thus, the presence of piRNAs in the ovary
may be adventitious.
A variety of othermousemodels have explored the involvement
of miRNAs in diverse cells and processes in the ovary.
Conditional deletion of Dicer1 in oocytes resulted in sterility
(Murchison et al., 2007). Although ovaries were grossly normal
and responsive to gonadotropins, oocytes were arrested inmeiosis
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I and showed spindle and chromosome congression defects.
Mutant oocytes had increased numbers of maternal transcripts
and up-regulation of genes involved in microtubule organization,
suggesting that regulated degradation of these classes of mRNAs
promoted by siRNAs, and miRNAs may be critical (Murchison
et al., 2007).
Conditional deletion of Dicer1 in granulosa cells also resulted
in sterility (Nagaraja et al., 2008). In addition to defects in the
uterus and oviduct, granulosa cells in the ovary showed increased
apoptosis, and fewer oocytes ovulated following superovulation,
with some oocytes remaining trapped inside luteinized follicles
(Nagaraja et al., 2008). Examination of a different group of ovaries
in which Dicer 1 was ablated only in granulosa cells revealed
that primordial follicle endowment was increased in Dicer1 = ,
leading to accelerated follicle recruitment that was, however,
negated by an increase in follicle degeneration (Lei et al., 2010).
The generation of a mouse model with a hypomorphic Dicer1
allele provided further information about the role of small RNAs
in the ovary. Mutant males were fertile, whereas females were
sterile, and this was specifically due to DICER1 deficiency,
because mutant females that received ovary transplantation
from a wild-type mouse were able to deliver normal offspring
(Otsuka et al., 2008). The mutant females showed luteal
insufficiency due to impaired angiogenesis of the corpora lutea.
The authors attributed this phenotype to the lack of two miRNAs,
miR17-5p and let7b, that regulate antiangiogenic factor Timp1.
However, injection of these miRNAs failed to completely rescue
pregnancy in mutant females, so that other small RNAs may be
involved.
The lin28/let7 system specifically affects for mouse germ cell
development and OR formation. Male and female mice ablated
of lin28, a RNA-binding protein that represses let7, showed early
defects in PGC proliferation. Whereas in males this was partially
corrected in adult life due to the continuous proliferation of
spermatogonial stem cells, females—whose germ cells do not
proliferate in the adult—formed a smaller OR and had reduced
fertility (Shinoda et al., 2013). This phenotype was replicated
by overexpression of let7, confirming the specific action of the
lin28/let7 system in regulating the size for the OR (Shinoda et al.,
2013).
As a clue to timing, hormones were found to regulate miRNA
expression in the granulosa cells of the mouse ovary. After in vitro
FSH treatment 31 miRNA species were differentially expressed in
granulosa cells. Interestingly, the expression of miR-29a and miR-
30d decreased significantly 12 h after FSH supplementation, and
then increased again by 48 h, suggestive of a complex feedback
circuit (Yao et al., 2010b). Following treatment with LH/hCG,
Fiedler et al. (2008) found that 13 miRNA’s were differentially
expressed in peri-ovulatory granulosa cells, and in particular
miR132 and miR-212 showed higher expression. The authors
found 77 putative mRNA targets of miR132 and miR-212, with
CTBP1, a known miR-132 target, among them.
More recently, in vitro experiments on primary human
granulosa cells that were transfected with anti-miR-15a, or
alternatively with pre-miR15a, showed that this miRNA affects
a series of processes including proliferation, apoptosis, and
hormone synthesis (Sirotkin et al., 2014). The same investigators
had previously identified a group of microRNAs involved in the
repression of estrogens, androgens, and progesterone (Sirotkin
et al., 2010). MiR-21 is also involved in the apoptosis of granulosa
cells during luteinization, but no target of its action has thus far
been identified (Carletti et al., 2010).
In vitro experiments in which miR-378 was over-expressed or
inhibited in porcine granulosa cells revealed a role in regulating
aromatase—and thus estradiol—levels. In addition, two miR-378
binding sites that were critical for its function were identified in
the aromatase coding region (Xu et al., 2011). It was also shown
thatmiR-133b binds toFoxl2mRNA, thus inhibiting its expression
and its ability to induce expression of StAR and aromatase (Dai
et al., 2013). Another miRNA, miR-224 was shown to be induced
by TGFb, and subsequently increases estradiol production by
granulosa cells in vitro through elevation of aromatase mRNA
levels (Yao et al., 2010a).
Experiments in the bovine ovary provided further information
about important miRNA action in the ovary and early embryo
development. miR-196a is a regulator of NOBOX expression in
the bovine ovary. A putative miRNA recognition element was
identified in the 30 UTR of NOBOX mRNA, and its binding
activity was confirmed by luciferase assays. Injection of miR-196a
in bovine embryos significantly decreased NOBOX expression at
both the mRNA and protein level (Tripurani et al., 2011). Because
NOBOX variants are associated with human POI, it would be
particularly interesting to assess the function of miR-196a in POI
patients.
In addition, bovine miR-181a was found to be involved in the
regulation of oocyte-specific NMP2, a protein critical for DNA
remodeling.MiR-181a is amaternally inheritedmiRNA that binds
to the 30 UTR of the NMP2 transcript and is involved in early
embryo development (Lingenfelter et al., 2011). Ma et al. (2011)
found a second role for miR-378, involvement in apoptosis during
luteinization, and identified IFNGR1 as a putative miR-378 target.
It remains to be seen if these functions are conserved in other
species.
The majority of experiments thus far have been conducted
in vitro on isolated cells, and most importantly, the function of
these miRNAs has not been evaluated with regard to the OR.
Nevertheless, these results demonstrate the relevance of small
regulatory RNAs in important processes of ovarian function.
Thus, their validation with in vivo models could provide exciting
results, identifying additional points of control in the regulation of
fertility and reproductive lifespan. One potential role of miRNA’s
in OR dynamics might well be in the initial recruitment of
primordial follicles. Consistent with such a role, when mouse
P3 and P5 ovaries were compared, 24 miRNA’s were found
differentially expressed. The authors showed that inhibition of
miR-145 induced primordial follicle recruitment, and suggested
that miR-145 as particularly associated with regulation of the
TGFb pathway in granulosa cells of primary follicles (Yang et al.,
2013). Microarray analysis of RNA profiles in a rat model of POI
identified 63 miRNA’s that were differentially expressed in POI
vs control ovaries. Once again, apoptosis was one of the main
putative pathways regulated by some of these miRNA’s, along with
other pathways including hormone response and prostaglandin
biosynthesis (Kuang et al., 2014).
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Recently, some miRNAs have also been reported to be
correlated with POI in human. Zhou et al. (2011) measured
miRNA expression in the serum of Chinese normal and POI
patients, and found 12 miRNA’s that were differentially expressed
(Zhou et al., 2011). Another study with a similar approach
found differentially expressed miRNA’s in plasma of POI patients,
suggesting that several pathways, including AKT signaling and
steroid hormone receptor pathways, might be regulated by these
miRNA’s. Additionally, the authors provided evidence for miR-
23a function in granulosa cell apoptosis and suggested a role
in POI (Yang et al., 2012). Rah et al. (2013) investigated the
association of miRNA variants in Korean POI patients and
described risk and protective effects of combinations of three
miRNA polymorphisms. However, none of the polymorphisms
was independently associated with POI (Rah et al., 2013). Finally,
a microarray analysis of POI patients identified a panel of 51
differentially expressed miRNA, several of which were further
validated. In particular, miR-22-3p, involved in apoptosis and
tumorigenesis, was suggested to be protective against POI and
negatively correlated with serum FSH (Dang et al., 2015).
One caveat for many of the miRNA determinations during
ovary aging is that they do not take into account the changing
composition of the ovary as the OR declines in normal aging or
in POI. This makes further work necessary to determine which
variations in miRNAmay be truly associated with POI from those
that merely reflect the loss of follicles.
INTERVENTIONS AFFECTING THE TIME
OF MENOPAUSE IN MOUSE MODELS
Becausewomen inmodern societies are reproducing later (Martin
et al., 2011), investigations of possible interventions to prolong
reproductive lifespan are increasing. Understandably, such studies
have been performed in animal models to try to understand
the mechanisms involved. However, a complication is that in
some mammals the ovary seems to be able to “sense” the size
of the follicle reserve and to compensate for both innate and
induced changes. The precise molecular pathways involved in
this “sensing” mechanism, and why such a mechanism exists, are
unknown. It may be necessary for the selection of the best quality
oocytes or to limit premature decline in numbers of primordial
follicles—that is, precisely in the mechanism whereby the time of
menopause is so narrowly restricted.
During embryonic development, for example, XO female mice
initially generate more germ cells than XX mice (Burgoyne and
Baker, 1985). However, the atresia following the peak production
of germ cells is much more extensive in the XO mice, leaving the
perinatal XO ovary with half the number of primordial follicles of
the XX ovary. Consequently, due to the reduced OR, XO female
mice become sterile earlier than XX mice. However, the rate of
depletion of the OR was found to be the same in XO vs XX mice
(Burgoyne and Baker, 1981). In other words, the same constant
proportion of primordial follicles is lost over time, allowing for a
delimited period of fertility in XO animals.
Interventions aiming rather to increase the OR have been
successful, but only temporarily. Animals transgenic for the anti-
apoptotic Bcl2 were born with a significantly larger population
of follicles (Flaws et al., 2001). This was likely due to BCL2
protection against apoptosis during embryonic and perinatal
development. However, a compensatory mechanism was again
soon evident in this case, with the OR returning to wild-type
levels by 30–60 days after birth (Flaws et al., 2001). Similar
results were obtained when pups were administered activin A,
a factor involved in germ cell proliferation before primordial
follicle formation (Bristol-Gould et al., 2006). The larger numbers
of follicles generated in treated mice did not persist until
puberty but were rather lost, again consistent with the existence
of a “census mechanism” that could aid in germ cell quality
control.
The size of the primordial follicle pool of Casp2 =  mice
was also larger than wild-type in P4 ovaries, and oocytes were
resistant to doxorubicin-induced apoptosis (Bergeron et al., 1998).
However, the dynamics of theORwas not evaluated, and it was not
shown if this phenotype persisted in older ovaries.
Another gene involved in cell death, Smpd1, encodes
sphingomyelinase phosphodiesterase 1, an important factor in
generating the signal for apoptosis. Smpd1 =  ovaries showed a
down-regulation of apoptosis at E13.5 in vitro, and Smpd1 = 
mice had an increased population of primordial, primary, and
pre-antral follicles both at P4 and P42. These findings suggested
a critical role for SMPD1 in controlling the size of the OR.
However, follicle numbers in older ovaries were not assessed
(Morita et al., 2000).
More lasting effects were demonstrated by ablation of pro-
apoptotic Bax in mice (Perez et al., 1999). Although the number
of follicles was the same in Bax =  and WT mice at birth,
significant follicle numbers and maturation were still seen up to
640 days post birth. However, aged Bax =  female mice failed to
become pregnant by natural reproduction, suggesting that quality
or performance was defective.
Another model manipulated Foxo3. Generation of transgenic
mice harboring a constitutively active form of Foxo3 (engineered
so that it could not be inactivated by phosphorylation) successfully
increased the ovarian follicle reserve throughout mouse
reproductive life (Pelosi et al., 2013). In addition, age-related
increase of gonadotropin levels was diminished in transgenic
animals and fertility was increased by up to 49%. Interestingly,
increased fertility remained significant throughout the entire
period of observation (Pelosi et al., 2013).
Ablation of interleukin 1 (Il1) also resulted in prolongation
of fertility in mice. There was no difference in follicle numbers
between Il1 =  and wild-type ovaries throughout reproductive
lifespan (apart from a transient increase in secondary and antral
follicles at 2.5 months that was later compensated). However, the
increase in fertility observed at 2.5 months of age persisted until
12months. This suggested that the observed decreased expression
of pro-inflammatory cytokines in Il1 =  ovaries might affect
follicle dynamics (Uri-Belapolsky et al., 2014).
Finally, inactivation of the mTOR pathway by rapamycin also
preserved primordial follicles in young 20 week old rats (Zhang
et al., 2013), and caloric restriction gave similar results (Li et al.,
2015). Especially if these effects prove to be long-lasting, these
approaches would provide epidemiological interventions that are
potentially at hand.
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CONCLUSION
Appropriate to the critical process by which reproduction and
continuity of a species aremaintained, formation and stabilization
of follicles is intricate. The ovary, like all organs, contains
cells of numerous lineages that must organize and cooperate
in coordinated regulation to produce competent and optimal
quality germ cells for fertilization and development of embryos.
A wide variety of pathways are coordinated, and the OR is thus
sensitive to many insults, that are often dosage-dependent. Thus,
in general, genes that cause POI in humans have loss-of-function
in only one allele; the resultant heterozygous women have the
pathognomonic reduction in OR; and as might be expected, the
knockout phenotypes in corresponding mouse models are far
more severe, frequently showing complete loss of OR.
Although many genes involved in ovary development
and function have been characterized, many more are vital
participants in the implicated pathways, and many other genes
and pathways that affect individual lineages and their interactions
are certainly still unidentified.
Among the important open questions is the extent to which
epigenetic changes through life may affect folliculogenesis and the
OR. Thus far, a few studies have examined DNAmethylation and
follicle dynamics following exposure to environmental toxicants
(Nilsson et al., 2012; Zhang et al., 2014); and initial assessment of
the epigenome has been analyzed for the effect of maternal aging
on oocyte quality (Ge et al., 2015). But, the effect of differential
DNA methylation or histone modifications on the OR during the
reproductive lifespan remains to be analyzed. A related issue that
is also open for more extensive study is the effect and interaction
of the more universal aging process with the uniquely partially
programmed aging of the OR reviewed here.
The major challenge in understanding human reproduction
for clinical use is the identification of reliable markers of the
OR. Today AMH and AFC are routinely used to assess the size
of the OR. A recent genome-wide association study has for the
first time taken follicle numbers into consideration and found
associations with menopause, identifying a variant in MCM8, a
DNA damage response gene, as a significant effector (Schuh-
Huerta et al., 2012). However, again more studies are needed
to find direct regulators of the OR that can be used in the
clinic to help in family planning. Notably, many potentially
useful targets for pharmacological intervention could provide
modalities either for birth control or for the augmentation of
fertility.
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